ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 682096 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 682096; 2) Community: the network communities that were significantly associated with the response to NSC 682096; 3) Molecule: the relationships between components within communities and NSC 682096; 4) MDR: the compounds that were significantly associated with the NSC 682096.

NSC Compound Enrichment Correlation
NSC 703105 Null 0.0430505868034761 0.17703596
NSC 703544 Null 0.0430505868034761 0.2383654
NSC 707904 Null 0.0430505868034761 0.39615873
NSC 710895 3-[(1H-Indol-3-ylethyl)amino]-2-(3-isopropoxyphenyl)-2H-pyrido[4,3-e]-1,2,4,-thiadiazine 1,1-dioxide 0.0430505868034761 0.36757338
NSC 714379 Null 0.0430505868034761 0.08222067
NSC 720386 Methyl-12.alpha.-acetoxy-5.beta.cholan-24-oate-3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclohexane 0.0430505868034761 0.31793196
NSC 721049 7Z-Plakortide H 0.0430505868034761 0.197564
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.0430505868034761 0.2903388
NSC 728038 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline 0.0430505868034761 0.33620608
NSC 733504 Everolimus 0.0430505868034761 -0.17446029
Total:119  Current:101    [First] [Prev] [Next] [Last]